Literature DB >> 1939511

Determination of HBsAg subtypes in different high risk populations using monoclonal antibodies.

P D Swenson1, J T Riess, L E Krueger.   

Abstract

Monoclonal antibodies with restricted specificity were used in a modified commercial enzyme immunoassay for detection of HBsAg to subtype HBsAg in sera from 122 Southeast Asian refugees entering the United States, 62 inmates of a correctional facility, and 19 homosexual men. This method was able to classify HBsAg as aywl-2, ayw3, ayw4, ayr, adw2, adw4, or adr. The HBsAg subtype was identified in 183 (90.1%) of the serum samples, but the serum HBsAg concentration was too low to determine the subtype for the 20 (9.9%) remaining samples. Among the Southeast Asian refugees, aywl-2 was demonstrated in 35 (33.0%) of the subtyped serum samples, the adw2 subtype was identified in 33 (31.1%) sera, adr was detected in 37 (34.9%) sera, and the adw 4 subtype as found in 1 (0.9%). The most common subtypes in Vietnam, Laos, and Cambodia were aywl-2, adw2, and adr, respectively. In prison inmates, the ayw3 subtype accounted for 31 (52.5%) of the subtyped serum samples, an ayw2 variant and the adw2 subtype were each found in 13 (22.0%) sera, and the aywl-2 subtype was detected in 2 (3.4%) sera. Many of these inmates admitted intravenous drug use. Among homosexual men, the adw2 subtype was identified in 16 (88.9%) of the subtyped serum samples and the ayw3 subtype was detected in 2 (11.1%) sera. This subtyping method can distinguish between most of the nine major HBsAg subtypes and can be easily performed with these monoclonal antibodies and commercially available reagents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939511     DOI: 10.1016/0166-0934(91)90004-j

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  9 in total

1.  HBsAg subtype distribution among different populations of HBsAg carriers in Spain.

Authors:  J E Echevarría; P León; J A López; A Tenorio; C J Domingo; J M Echevarría
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082

2.  Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela.

Authors:  L Blitz; F H Pujol; P D Swenson; L Porto; R Atencio; M Araujo; L Costa; D C Monsalve; J R Torres; H A Fields; S Lambert; C Van Geyt; H Norder; L O Magnius; J M Echevarría; L Stuyver
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

3.  Patient-to-patient transmission of hepatitis B in a dermatology practice.

Authors:  W G Hlady; R S Hopkins; T E Ogilby; S T Allen
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

4.  Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission.

Authors:  R Repp; S Rhiel; K H Heermann; S Schaefer; C Keller; P Ndumbe; F Lampert; W H Gerlich
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

5.  Mutation Reporter Tool: an online tool to interrogate loci of interest, with its utility demonstrated using hepatitis B virus.

Authors:  Trevor G Bell; Anna Kramvis
Journal:  Virol J       Date:  2013-02-23       Impact factor: 4.099

6.  Evaluation of intra-host variants of the entire hepatitis B virus genome.

Authors:  Sumathi Ramachandran; Xiangjun Zhai; Hong Thai; Davis S Campo; Guoliang Xia; Lilia M Ganova-Raeva; Jan Drobeniuc; Yury E Khudyakov
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

7.  Hepatitis B virus S gene escape mutants.

Authors:  Michael A Purdy
Journal:  Asian J Transfus Sci       Date:  2007-07

8.  Bioinformatics tools for small genomes, such as hepatitis B virus.

Authors:  Trevor G Bell; Anna Kramvis
Journal:  Viruses       Date:  2015-02-16       Impact factor: 5.048

9.  Detection of circulating hepatitis B virus immune escape and polymerase mutants among HBV-positive patients attending Institut Pasteur de Bangui, Central African Republic.

Authors:  Giscard Wilfried Koyaweda; Juliette Rose Ongus; Eunice Machuka; John Juma; Rosaline Macharia; Narcisse Patrice Komas; Roger Pelle
Journal:  Int J Infect Dis       Date:  2019-11-01       Impact factor: 3.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.